Filing Details
- Accession Number:
- 0001209191-20-063101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-11 21:00:07
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-11 21:00:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1478320 | Adaptive Biotechnologies Corp | ADPT | Biological Products, (No Disgnostic Substances) (2836) | 270907024 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1820885 | Susan Bobulsky | C/O Adaptive Biotechnologies Corp. 1551 Eastlake Ave E Ste 200 Seattle WA 98102 | Svp, Diagnostics, Clonoseq | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-10 | 25,000 | $1.98 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-10 | 25,000 | $55.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-10 | 25,000 | $0.00 | 25,000 | $1.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2024-10-13 | No | 4 | M | Direct |
Footnotes
- These transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019.
- All options are fully exercisable.